在肥胖患者中使用与肥胖相关的基因的下一代测序的变异分布和新变异的鉴定:土耳其的单中心经验。

IF 0.9 4区 医学 Q4 GENETICS & HEREDITY
Molecular Syndromology Pub Date : 2025-05-01 Epub Date: 2024-10-04 DOI:10.1159/000541313
Ozlem Anlas, Ozge Ozalp, Suleyman Cetinkunar
{"title":"在肥胖患者中使用与肥胖相关的基因的下一代测序的变异分布和新变异的鉴定:土耳其的单中心经验。","authors":"Ozlem Anlas, Ozge Ozalp, Suleyman Cetinkunar","doi":"10.1159/000541313","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Obesity has become a common public health problem all over the world today. In recent years, studies on the genetic etiology of obesity have gained importance. As a result of these studies, 127 obesity-related loci have been identified.</p><p><strong>Objectives: </strong>The aim of this work was to screen obesity-related genes and review the literature.</p><p><strong>Methods: </strong>In this retrospective study, 41 obesity-related genes were screened in 116 patients by next-generation sequencing. These genes are <i>DYRK1B</i>, <i>LEP</i>, <i>LEPR</i>, <i>MC4R</i>, <i>NR0B2</i>, <i>POMC</i>, <i>UCP3</i>, <i>ADRB2</i>, <i>ADRB3</i>, <i>AGRP</i>, <i>MC3R</i>, <i>NTRK2</i>, <i>PCSK1</i>, <i>SIM1</i>, <i>CARTPT</i>, <i>ENPP1</i>, <i>PPARG</i>, <i>PPARGC1B, PYY</i>, <i>SDC3</i>, <i>UCP1</i>, <i>ADIPOQ</i>, <i>PBEF (NAMP)</i>, <i>ADN (CFD)</i>, <i>RETN</i>, <i>PGC1 (PPARGC1A)</i>, <i>CCK</i>, <i>NPY</i>, <i>GLUT4 (SLC2A4)</i>, <i>ADD1</i>, <i>SREBP1 (SREBF1)</i>, <i>PTP1B (PTPN1)</i>, <i>IRS-1</i>, <i>GHRL</i>, <i>BDNF</i>, <i>NEGR1, SH2B1</i>, <i>GIPR</i>, <i>TMEM18</i>, <i>FTO</i>, and <i>SLC22A1</i>.</p><p><strong>Results: </strong>Seventy-six of our patients were female, and 40 were male. As a result, 43 variants were detected in 39 (34.4%) patients. Of these, <i>GHRL</i> c.152G>A, <i>MC4R</i> c.496G>A, SH2B1 c.2083G>A, <i>GIPR</i> c.548G>A, <i>ADIPOQ</i> c.268G>A, and <i>BDNF</i> c.5C>T variants have been previously reported in the literature. In addition to the aforementioned variants, there are 37 novel variants that have not been previously reported. Among these, we classified the <i>UCP3</i> c.126 + 1G>T variant as \"Pathogenic\" according to the American College of Medical Genetics and Genomics (ACMG) criteria. Four of 37 novel variants, respectively, <i>ADRB2</i> c.1160_1163delTTGT (p.Phe387Trp*55), <i>MC4R</i> c.895C>T (p.Pro299Ser), <i>POMC</i> c.304C>T (p.Gln102*), and <i>NR0B2</i> c.265C>T (p.Gln89*), were classified as \"Likely Pathogenic.\" A total of 32 novel variants among 37 novel variants were categorized as variants of uncertain significance.</p><p><strong>Conclusions: </strong>Understanding the genetics of obesity is an essential step toward treating and preventing this disease, which has become a global health problem. With this study, we wanted to contribute to the literature by reporting previously reported and novel variants we detected in our patients with obesity.</p>","PeriodicalId":48566,"journal":{"name":"Molecular Syndromology","volume":"16 3","pages":"208-215"},"PeriodicalIF":0.9000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12136547/pdf/","citationCount":"0","resultStr":"{\"title\":\"Distribution of Variants and Identification of Novel Variants in Patients with Obesity Using Next-Generation Sequencing in Genes Associated with Obesity: A Single-Center Experience in Turkey.\",\"authors\":\"Ozlem Anlas, Ozge Ozalp, Suleyman Cetinkunar\",\"doi\":\"10.1159/000541313\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Obesity has become a common public health problem all over the world today. In recent years, studies on the genetic etiology of obesity have gained importance. As a result of these studies, 127 obesity-related loci have been identified.</p><p><strong>Objectives: </strong>The aim of this work was to screen obesity-related genes and review the literature.</p><p><strong>Methods: </strong>In this retrospective study, 41 obesity-related genes were screened in 116 patients by next-generation sequencing. These genes are <i>DYRK1B</i>, <i>LEP</i>, <i>LEPR</i>, <i>MC4R</i>, <i>NR0B2</i>, <i>POMC</i>, <i>UCP3</i>, <i>ADRB2</i>, <i>ADRB3</i>, <i>AGRP</i>, <i>MC3R</i>, <i>NTRK2</i>, <i>PCSK1</i>, <i>SIM1</i>, <i>CARTPT</i>, <i>ENPP1</i>, <i>PPARG</i>, <i>PPARGC1B, PYY</i>, <i>SDC3</i>, <i>UCP1</i>, <i>ADIPOQ</i>, <i>PBEF (NAMP)</i>, <i>ADN (CFD)</i>, <i>RETN</i>, <i>PGC1 (PPARGC1A)</i>, <i>CCK</i>, <i>NPY</i>, <i>GLUT4 (SLC2A4)</i>, <i>ADD1</i>, <i>SREBP1 (SREBF1)</i>, <i>PTP1B (PTPN1)</i>, <i>IRS-1</i>, <i>GHRL</i>, <i>BDNF</i>, <i>NEGR1, SH2B1</i>, <i>GIPR</i>, <i>TMEM18</i>, <i>FTO</i>, and <i>SLC22A1</i>.</p><p><strong>Results: </strong>Seventy-six of our patients were female, and 40 were male. As a result, 43 variants were detected in 39 (34.4%) patients. Of these, <i>GHRL</i> c.152G>A, <i>MC4R</i> c.496G>A, SH2B1 c.2083G>A, <i>GIPR</i> c.548G>A, <i>ADIPOQ</i> c.268G>A, and <i>BDNF</i> c.5C>T variants have been previously reported in the literature. In addition to the aforementioned variants, there are 37 novel variants that have not been previously reported. Among these, we classified the <i>UCP3</i> c.126 + 1G>T variant as \\\"Pathogenic\\\" according to the American College of Medical Genetics and Genomics (ACMG) criteria. Four of 37 novel variants, respectively, <i>ADRB2</i> c.1160_1163delTTGT (p.Phe387Trp*55), <i>MC4R</i> c.895C>T (p.Pro299Ser), <i>POMC</i> c.304C>T (p.Gln102*), and <i>NR0B2</i> c.265C>T (p.Gln89*), were classified as \\\"Likely Pathogenic.\\\" A total of 32 novel variants among 37 novel variants were categorized as variants of uncertain significance.</p><p><strong>Conclusions: </strong>Understanding the genetics of obesity is an essential step toward treating and preventing this disease, which has become a global health problem. With this study, we wanted to contribute to the literature by reporting previously reported and novel variants we detected in our patients with obesity.</p>\",\"PeriodicalId\":48566,\"journal\":{\"name\":\"Molecular Syndromology\",\"volume\":\"16 3\",\"pages\":\"208-215\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12136547/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Syndromology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000541313\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Syndromology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000541313","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/4 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

摘要

背景:肥胖已成为当今世界普遍存在的公共健康问题。近年来,肥胖的遗传病因学研究日益受到重视。作为这些研究的结果,127个与肥胖相关的基因座已经被确定。目的:筛选肥胖相关基因并复习相关文献。方法:采用新一代测序技术,从116例患者中筛选41个肥胖相关基因。这些基因是DYRK1B、LEP、LEPR、MC4R、NR0B2、POMC、UCP3、ADRB2、ADRB3、AGRP、MC3R、NTRK2、PCSK1、SIM1、CARTPT、ENPP1、PPARG、PPARGC1B、PYY、ssd3、UCP1、ADIPOQ、PBEF (NAMP)、ADN (CFD)、RETN、PGC1 (PPARGC1A)、CCK、NPY、GLUT4 (SLC2A4)、ADD1、SREBP1 (SREBF1)、PTP1B (PTPN1)、IRS-1、GHRL、BDNF、NEGR1、SH2B1、GIPR、TMEM18、FTO和SLC22A1。结果:女性76例,男性40例。结果,在39例(34.4%)患者中检测到43种变异。其中,GHRL c.152G>A、MC4R c.496G>A、SH2B1 c.2083G>A、GIPR c.548G>A、ADIPOQ c.268G>A和BDNF c.5C>T变异已在文献中报道。除了上述的变体,还有37种以前没有报道过的新变体。其中,根据美国医学遗传学与基因组学学院(ACMG)的标准,我们将UCP3 c.126 + 1G >t变异归为“致病性”。在37个新变异中,ADRB2 c.1160_1163delTTGT (p.p phe387trp *55)、MC4R c.895C>T (p.p pro299ser)、POMC c.304C>T (p.p gln102 *)和NR0B2 c.265C>T (p.p gln89 *)分别被归类为“可能致病”。37个新变异中有32个新变异被归类为意义不确定的变异。结论:了解肥胖的遗传学是治疗和预防肥胖的重要一步,肥胖已经成为一个全球性的健康问题。在这项研究中,我们希望通过报告我们在肥胖患者中发现的先前报道和新的变异来为文献做出贡献。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Distribution of Variants and Identification of Novel Variants in Patients with Obesity Using Next-Generation Sequencing in Genes Associated with Obesity: A Single-Center Experience in Turkey.

Background: Obesity has become a common public health problem all over the world today. In recent years, studies on the genetic etiology of obesity have gained importance. As a result of these studies, 127 obesity-related loci have been identified.

Objectives: The aim of this work was to screen obesity-related genes and review the literature.

Methods: In this retrospective study, 41 obesity-related genes were screened in 116 patients by next-generation sequencing. These genes are DYRK1B, LEP, LEPR, MC4R, NR0B2, POMC, UCP3, ADRB2, ADRB3, AGRP, MC3R, NTRK2, PCSK1, SIM1, CARTPT, ENPP1, PPARG, PPARGC1B, PYY, SDC3, UCP1, ADIPOQ, PBEF (NAMP), ADN (CFD), RETN, PGC1 (PPARGC1A), CCK, NPY, GLUT4 (SLC2A4), ADD1, SREBP1 (SREBF1), PTP1B (PTPN1), IRS-1, GHRL, BDNF, NEGR1, SH2B1, GIPR, TMEM18, FTO, and SLC22A1.

Results: Seventy-six of our patients were female, and 40 were male. As a result, 43 variants were detected in 39 (34.4%) patients. Of these, GHRL c.152G>A, MC4R c.496G>A, SH2B1 c.2083G>A, GIPR c.548G>A, ADIPOQ c.268G>A, and BDNF c.5C>T variants have been previously reported in the literature. In addition to the aforementioned variants, there are 37 novel variants that have not been previously reported. Among these, we classified the UCP3 c.126 + 1G>T variant as "Pathogenic" according to the American College of Medical Genetics and Genomics (ACMG) criteria. Four of 37 novel variants, respectively, ADRB2 c.1160_1163delTTGT (p.Phe387Trp*55), MC4R c.895C>T (p.Pro299Ser), POMC c.304C>T (p.Gln102*), and NR0B2 c.265C>T (p.Gln89*), were classified as "Likely Pathogenic." A total of 32 novel variants among 37 novel variants were categorized as variants of uncertain significance.

Conclusions: Understanding the genetics of obesity is an essential step toward treating and preventing this disease, which has become a global health problem. With this study, we wanted to contribute to the literature by reporting previously reported and novel variants we detected in our patients with obesity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular Syndromology
Molecular Syndromology Biochemistry, Genetics and Molecular Biology-Genetics
CiteScore
1.70
自引率
9.10%
发文量
67
期刊介绍: ''Molecular Syndromology'' publishes high-quality research articles, short reports and reviews on common and rare genetic syndromes, aiming to increase clinical understanding through molecular insights. Topics of particular interest are the molecular basis of genetic syndromes, genotype-phenotype correlation, natural history, strategies in disease management and novel therapeutic approaches based on molecular findings. Research on model systems is also welcome, especially when it is obviously relevant to human genetics. With high-quality reviews on current topics the journal aims to facilitate translation of research findings to a clinical setting while also stimulating further research on clinically relevant questions. The journal targets not only medical geneticists and basic biomedical researchers, but also clinicians dealing with genetic syndromes. With four Associate Editors from three continents and a broad international Editorial Board the journal welcomes submissions covering the latest research from around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信